stereotactic ablative radiotherapy (SABR)
stereotactic ablative radiotherapy (SABR) is a radiation therapy with 17 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
3
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers
A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy
Clinical Trials (17)
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers
A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy
SABR-SCAN Trial for Pulmonary Oligometastases
Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART)
A Dose-escalation Trial of Stereotactic Ablative Body Radiotherapy for Non-spine Bone & Lymph Node Oligometastates
Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers
CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy
Stereotactic Ablative Radiotherapy for Refractory Ventricular Tachycardia
Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)
The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)
The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer
The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer
A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection
Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC
All 17 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 17